Use of everted sacs of mouse small intestine as enzyme sources for the study of drug oxidation activities in vitro

References

• BRIAN, W. R., SRIVASTAVA, P. K., UMBENHAUER, D. R., LLOYD, R. S. and GUENGERICH, F. P., 1989, Expression of a human liver cytochrome P450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Biochemistry, 28, 4993–4999.
   PubMed Web of Science ®Google Scholar
• BERTZ, R. J. and GRANNEMAN, G. R., 1997, Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clinical Pharmacokinetics, 32, 210–258.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1995, Human cytochrome P450 enzymes. In P. R. Oritiz de Montellano (ed.), Cytochrome P450 (New York: Plenum), pp. 473–535.
   Google Scholar
• GUENGERICH, F. P., 1999, Cytochrome P-450 3A4: regulation and role in drug metabolism. Annual Reviews in Pharmacology and Toxicology, 39, 1–17.
   PubMed Web of Science ®Google Scholar
• HANSEN, T., BORLAK, J. and BADER, A., 2000, Cytochrome P450 enzyme activity and protein expression in primary porcine enterocyte and hepatocyte cultures. Xenobiotica, 30, 27–46.
   PubMed Web of Science ®Google Scholar
• HASHIMOTO, Y., SASA, H., SHIMOMURA, M. and INui, K., 1998, Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats. Pharmaceutical Research, 15, 1609–1613.
   PubMed Web of Science ®Google Scholar
• HUGHES, J. A., AVRUTSKAYA, A. V., BROUWER, K. L., WICKSTROM, E. and JULIANO, R. L., 1995, Radiolabeling of methylphosphonate and phosphorothioate oligonucleotides and evaluation of their transport in everted rat jejunum sacs. Pharmaceutical Research, 126, 817–824.
   Web of Science ®Google Scholar
• IATSIMIRSKAIA, E., TULEBAEV, S., STOROZHUK, E., UTKIN, I., Smith, D., Gerber, N. and KOUDRIAKOVA, T., 1997, Metabolism of rifabutin in human enterocyte and liver microsomes : kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents. Clinical Pharmacology and Therapeutics, 61, 554–562.
   PubMed Web of Science ®Google Scholar
• JACOBSEN, W., KIRCHNER, G., HALLENSLEBEN, K., MANCINELLI, L., DETERS, M., HACKBARTH, I., BANER, K., BENET, L. Z., SEWING, K. F. and CHRISTIANS, U., 1999, Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyrre A reductase inhibitor lovastatin and comparison with pravastatin. Journal of Pharmacology and Experimental Therapeutics, 291, 131–139.
   PubMed Web of Science ®Google Scholar
• KASHFI, K., MCDOUGALL, C. J. and DANNENBERG, A. J., 1995, Comparative effects of omeprazole OR xenobiotic metabolizing enzymes in the rat and human. Clinical Pharmacology and Therapeutics, 58, 625–630.
   PubMed Web of Science ®Google Scholar
• KITAGAWA, S., SATO, K., SATO, S. and SASAKI, M., 1996, Absorption of methochlorpromazine in rat small intestinal everted sac. Biological and Pharmaceutical Bulletin, 19, 998–1000.
   PubMed Web of Science ®Google Scholar
• KRISHNA, D. R. and KLOTZ, U., 1994, Extrahepatic metabolism of drugs in humans. Clinical Pharmacokinetics, 26, 144–160.
   PubMed Web of Science ®Google Scholar
• KRONBACH, T., MATHYS, D., GUT, J., CATIN, T. and MEYER, U. A., 1987, High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextro-methorphan 0-demethylase in microsomes and purified cytochrome P450 isozymes of human liver. Analytical Biochemistry, 162, 24–32.
   PubMed Web of Science ®Google Scholar
• LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• LANG, D. and BoCKE R., 1995, Highly sensitive and specific high-performance liquid chromatographic analysis of 7-hydroxywarfarin, a marker for human cytochrome P450 2C9 activity. Journal of Chromatography B: Biomedical Applications, 672, 305–309.
   Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT, D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   PubMedGoogle Scholar
• PAINE, M. F., KHALIGHI, M., FISHER, J. M., SHEN, D. D., KUNZE, K. L., MARSH, C. L., PERKINS, J. D. and THUMMEL, K. E., 1997, Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. Journal of Pharmacology and Experimental Therapeutics, 283, 1552–1562.
   PubMed Web of Science ®Google Scholar
• PAINE, M. F., SHEN, D. D., KUNZE, K. L., PERKINS, J. D., MARSH, C. L., McVicAR, J. P., BARR, D. M., GILLIES, B. S. and THUMMEL, K. E., 1996, First-pass metabolism of midazolam by the human intestine. Clinical Pharmacology and Therapeutics, 60, 14–24.
   PubMed Web of Science ®Google Scholar
• PETER, R., BOCKER, R., BEAUNE, P. H., IWASAKI, M., GUENGERICH, F. P. and YANG, C. S., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P45011E1. Chemical Research in Toxicology, 3, 566–573.
   PubMed Web of Science ®Google Scholar
• ROSENBERG, D. W. and MANKOWSKI, D. C., 1994, Induction of cyp2e-1 protein in mouse colon. Carcinogenesis, 15, 73–78.
   PubMed Web of Science ®Google Scholar
• SAKUMA, T., TAKAI, M., ENDO, Y., KUOIWA, M., OHARA, A., JARUKAMJORN, K., HONMA, R. and NEMOTO, N., 2000, A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Archives of Biochemistry and Biophysics, 377, 153–162.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• STRALKA, D. J. and STROBEL, H. W., 1989, Cytochrome P450 activity and distribution in the human colon mucosa. Cancer, 64, 2111–2116.
   PubMed Web of Science ®Google Scholar
• VICKERS, A. E., FISHER, R. L., BRENDEL, K., GUERTLER, J., DANNECKER, R., KELLER, B. and FISCHER, V., 1995, Sites of biotransformation for the cyclosporin derivative SDZ IMM 125 using human liver and kidney slices and intestine. Comparison with rat liver slices and cyclosporin A metabolism. Drug Metabolism and Disposition, 23, 327–333.
   PubMed Web of Science ®Google Scholar
• VICKERS, A. E., FISCHER, V., CONNORS, S., FISHER, R. L., BALDECK, J. P., MAURER, G. and BRENDEL, K., 1992, Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines. Drug Metabolism and Disposition, 20, 802–809.
   PubMed Web of Science ®Google Scholar
• WALDRON, K. W., JOHNSON, I. T. and FENWICK, G. R. (eds), 1994, Food and Cancer Prevention: Chemical and Biological Aspects. Special publication 123 (London: Springer).
   Google Scholar
• WATKINS, P. B., WRIGHTON, S. A., SCHUETZ, E. G., MOLOWA, D. T. and GUZELIAN, P. S., 1987, Identification of glucocorticoid-inducible cytochromes P450 in the intestinal mucosa of rats and man. Journal of Clinical Investigation, 80, 1029–1036.
   PubMed Web of Science ®Google Scholar
• WILSON, T. H. and WISEMAN, G., 1954, The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. Journal of Physiology, 123, 116–125.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H., Guo, Z., PERSMARK, M., MIMURA, M., INOUE, K., GUENGERICH, F. P. and SHIMADA, T., 1994, Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Molecular Pharmacology, 46, 568–577.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H., INouE, K. and SHIMADA, T., 1998, Roles of two allelic variants (Arg144Cys and Ile359Leu) of cytochrome P450 2C9 in the oxidation of tolbutamide and warfarin by human liver microsomes. Xenobiotica, 28, 103–115.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H. and SHIMADA, T., 1997, Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Archives of Biochemistry and Biophysics, 346, 161–169.
   PubMed Web of Science ®Google Scholar
• YANAGIMOTO, T., IToH, S., SAWADA, M. and KAMATAKI, T., 1997, Mouse cytochrome P450 (CYP3A11): predominant expression in liver and capacity to activate afiatoxin B1. Archives of Biochemistry and Biophysics, 340, 215–218.
   PubMed Web of Science ®Google Scholar
• ZHANG, Q. Y., DUNBAR, D., OSTROWSKA, A., ZEISLOFT, S., YANG, J. and KAMINSKY, L. S., 1999, Characterization of human small intestinal cytochromes P450. Drug Metabolism and Dispositicn, 27, 804–809.
   PubMed Web of Science ®Google Scholar